Ivermectin for Post Exposure Prophylaxis of Covid-19

Summary

Post exposure prophylaxis of healthy contacts is among the measures used for outbreak control of several infectious diseases (e.g., pandemic influenza). No agent is known to be effective in preventing COVID-19, but Ivermectin is one of the drugs that have shown antiviral activity against SARS-CoV-2 in the laboratory. This study aims to evaluate the effect of post exposure prophylaxis with Ivermectin after exposure to COVID-19 among the asymptomatic close contacts.

Timeline

Start

2022-02-16

Primary completion

2022-05-31

Completion

2022-10-11

Outcome

Outcome not reported

Stopped: “Poor response”

Drugs

Indications